Soft mist inhalers Archives - Aquilon Pharma https://aquilonpharma.com/products_category/soft-mist-inhalers/ A revolution in the efficacy of inhaled drugs Mon, 26 May 2025 13:49:11 +0000 en-US hourly 1 https://aquilonpharma.com/wp-content/uploads/2023/05/cropped-favicon_ap_colored-32x32.png Soft mist inhalers Archives - Aquilon Pharma https://aquilonpharma.com/products_category/soft-mist-inhalers/ 32 32 AQ002&3M https://aquilonpharma.com/product/aq002m/ Wed, 14 Jun 2023 09:55:46 +0000 https://aquilonpharma.djm.eu/?post_type=products&p=1275 Innovative Soft Mist Inhaler formulation, based on the excipient technology.

L’article AQ002&3M est apparu en premier sur Aquilon Pharma.

]]> AQ002M, fixed ICS-LABA combination for soft mist inhaler

By reformulating existing ICS and LABA with its proprietary excipient technology, Aquilon Pharma makes ICS-LABA combinations soluble in water. This allows AQ002M to be optimized for any type of Soft Mist Inhaler.

aq002m

The answer to today’s needs in the field of asthma medication

The recently revised therapy standards advocates the use of a fixed combination of low dose formoterol and ICS as basic treatment of asthma.

ICS-LABA can be delivered via several types of devices, however it is currently not deliverable via Soft Mist Inhaler. Unfortunately, there is no ICS-LABA in liquid formulation available yet for these devices.

Aquilon Pharma’s AQ002M formulation is the key. Aquilon Pharma is currently the ONLY development company capable of formulating an Ultra Low Dose Budesonide-Formoterol for lung delivery through Soft Mist Inhaler, what makes AQoo2M a real Groundbreaker*

*Groundbreaker = Ultra low dose fixed combination Budesonide – Formoterol for PRN use, delivered by Innovative Inhaler based on the Soft Mist Inhaler technology

L’article AQ002&3M est apparu en premier sur Aquilon Pharma.

]]> AQ001M https://aquilonpharma.com/product/aq001m/ Tue, 16 May 2023 14:20:09 +0000 https://aquilonpharma.djm.eu/?post_type=products&p=934 A soluble steroid for Soft Mist Inhalers.

L’article AQ001M est apparu en premier sur Aquilon Pharma.

]]> AQ001M, a soluble steroid for Soft Mist Inhaler

By reformulating existing ICS with its proprietary excipient, Aquilon Pharma makes ICS soluble in water.

The answer to today’s needs in the field of asthma medication

Inhaled corticosteroids (ICS) are the basic treatment option for suppressing airway inflammation.

ICS can be delivered via several types of devices, but it is not commonly delivered via Soft Mist Inhaler.

Aquilon Pharma is currently the ONLY development company capable of formulating an Ultra Low Dose Budesonide for lung delivery through Soft Mist Inhaler.

Aquilon Pharma’s AQ001M formulation is the key.

L’article AQ001M est apparu en premier sur Aquilon Pharma.

]]>